Early Phase 2 data from the SKYLINE trial suggest SPY001, a next-generation anti-α4β7 therapy for ulcerative colitis, could match existing biologics in efficacy while significantly improving dosing convenience through an extended half-life. Beyond clinical remission and endoscopic improvement, the real innovation lies in design—quarterly or…
In a bid to close persistent colorectal cancer (CRC) screening gaps, Guardant Health has launched a community grant program offering…
The 2025 Identity Theft Resource Center report confirms what many physician-owners are feeling: cyberattacks are no longer random — they’re…
UMass’ Division of Gastroenterology has completed its first Full-Thickness Resection Device (FTRD) procedure, marking an expansion in advanced endoscopic capabilities.…
Austin Gastroenterology will open a new South Austin location on March 2, consolidating its former James Casey and Southwest clinics…
Thought Leadership
Gastroenterology is rapidly becoming a focal point for innovation, with AI, robotics, and digital workflows transforming how diseases are detected, managed, and treated. From…
As administrative burden and payer friction push more physicians toward burnout, a…
Medical gaslighting, defined as the dismissal or minimization of patient-reported symptoms in…
The intersection of AI and gut health is attracting massive consumer interest—and…